Grant Supports Important Advancement in Understanding Type 1 Diabetes

Teaching. Discovering. Caring.

About EVMS

Departments

Giving

Prospective Students

Current Students

Residents & Fellows

Alumni

Faculty

Staff & Administrators

Patients

Community

Media

Get Social with EVMS

Connect with EVMS social media.

Featured Content

	Get updates on construction activity around the campus
	Download the Winter 2012 issue of EVMS Magazine (PDF).
	Keep updated on EVMS' website-improvement project on the blog.
	Read the Executive Summary of the EVMS Strategic Plan (PDF) and check out the blog.
	Learn more about EVMS. Download the 2011-2012 Facts & Figures booklet (PDF).
	All the facts you need about EVMS for 2009-2010. Download the 2009-2010 Factbook (PDF).

Grant Supports Important Advancement in Understanding Type 1 Diabetes

Monday, 07 September 2009 17:05

Scientists at Eastern Virginia Medical School’s Strelitz Diabetes Center have been awarded a two-year grant totaling $472,683 by the Juvenile Diabetes Research Foundation (JDRF).

The center’s research team, led by Jerry Nadler, MD, professor and chair of internal medicine and director of the center, has been studying the role of an enzyme called 12- Lipoxygenase (12-LO) in damaging insulin-producing beta cells, a condition that leads to Type 1 Diabetes. “We have successfully identified a vital step in the development of Type 1 diabetes and we are hopeful that blocking this enzyme could hold the key to engineering breakthrough new treatments,” Dr. Nadler said.

“JDRF is thrilled to be supporting Dr. Nadler’s work at EVMS as this research may represent an important step toward the development of a new therapeutic strategy for treating type 1 diabetes,” said Patricia Kilian, Ph.D., director of regeneration at JDRF.

Watch for the Fall issue of EVMS Magazine for more information about this research.

Last Updated on Monday, 07 September 2009 18:57